så sædvanligt Burma reslizumab teva Potentiel mister temperamentet konsulent
Australian Public Assessment Report Reslizumab
A program supporting CINQAIR® (reslizumab) Injection patients
Dosing and Administration
Predicting Responders to Reslizumab after 16 Weeks of Treatment Using an Algorithm Derived from Clinical Studies of Patients wit
These highlights do not include all the information needed to use CINQAIR safely and effectively. See full prescribing information for CINQAIR.CINQAIR® (reslizumab) injection, for intravenous useInitial U.S. Approval: 2016